Hyperhomocysteinemia and dyslipidemia in point mutation G307S of cystathionine β-synthase-deficient rabbit generated using CRISPR/Cas9

被引:6
|
作者
Zhang, Ting [1 ,2 ]
Lu, Rui [3 ]
Chen, Yibing [1 ,2 ]
Yuan, Yuguo [1 ,2 ]
Song, Shaozheng [4 ]
Yan, Kunning [5 ]
Zha, Yiwen [5 ]
Zhuang, Wenwen [5 ]
Cheng, Yong [1 ,2 ]
Liang, Jingyan [5 ]
机构
[1] Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Jiangsu, Peoples R China
[2] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China
[3] Jiangsu Food & Pharmaceut Sci Coll, Sch Pharm, Huaian 223003, Jiangsu, Peoples R China
[4] Taihu Univ Wuxi, Sch Nursing, Wuxi 214000, Jiangsu, Peoples R China
[5] Yangzhou Univ, Med Coll, Inst Translat Med, Yangzhou 225001, Jiangsu, Peoples R China
关键词
Cystathionine beta-synthase; Hyperhomocysteinemia; Dyslipidemia; Rabbits; CRISPR/Cas9; G307S mutation; PLASMA HOMOCYSTEINE CONCENTRATIONS; FOLIC-ACID SUPPLEMENTATION; BIOMEDICAL-RESEARCH; TRANSGENIC RABBIT; MOLECULAR-BASIS; RISK-FACTOR; HOMOCYSTINURIA; CHOLESTEROL; EXPRESSION; PHENOTYPE;
D O I
10.1186/s12944-020-01394-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Congenital hyper-homocysteinemia (HHcy) is caused by a defective cystathionine beta-synthase (CBS) gene, and is frequently associated with dyslipdemia. The aim of this study was to further elucidate the effect of mutatedCBSgene on circulating lipids using a rabbit model harboring a homozygous G307S point mutation inCBS. Methods: CRISPR/Cas9 system was used to edit theCBSgene in rabbit embryos. The founder rabbits were sequenced, and their plasma homocysteine (Hcy) and lipid profile were analyzed. Results: Six CBS-knockout (CBS-KO) founder lines with biallelic modifications were obtained. Mutation in CBS caused significant growth retardation and high mortality rates within 6 weeks after birth. In addition, the 6-week oldCBS-KO rabbits showed higher plasma levels of Hcy, triglycerides (TG), total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) compared to the age-matched wild-type (WT) controls. Histological analysis of the mutants showed accumulation of micro-vesicular cytoplasmic lipid droplets in the hepatocytes. However, gastric infusion of vitamin B and betaine complex significantly decreased the plasma levels of TG, TC and LDL-C in theCBS-KO rabbits, and alleviated hepatic steatosis compared to the untreated animals. Conclusion: A CBSG307S rabbit model was generated that exhibited severe dyslipidemia when fed on a normal diet, indicating that G307S mutation in theCBSgene is a causative factor for dyslipidemia.
引用
收藏
页数:11
相关论文
共 19 条
  • [11] Targeted mutation of GA20ox-2 gene using CRISPR/Cas9 system generated semi-dwarf phenotype in rice
    Santoso, T. J.
    Trijatmiko, K. R.
    Char, S. N.
    Yang, B.
    Wang, K.
    1ST INTERNATIONAL CONFERENCE ON GENETIC RESOURCES AND BIOTECHNOLOGY, 2020, 482
  • [12] Development and characterization of anti-glycopeptide monoclonal antibodies against human podoplanin, using glycan-deficient cell lines generated by CRISPR/Cas9 and TALEN
    Kaneko, Mika K.
    Nakamura, Takuro
    Honma, Ryusuke
    Ogasawara, Satoshi
    Fujii, Yuki
    Abe, Shinji
    Takagi, Michiaki
    Harada, Hiroyuki
    Suzuki, Hiroyoshi
    Nishioka, Yasuhiko
    Kato, Yukinari
    CANCER MEDICINE, 2017, 6 (02): : 382 - 396
  • [13] Investigating The Correction of IVS II-1 (G> A) Mutation in HBB Gene in TLS-12 Cell Line Using CRISPR/Cas9 System
    Servatian, Nazli
    Abroun, Saeid
    Fazeli, Seyed Abolhassan Shahzadeh
    Soleimani, Masoud
    CELL JOURNAL, 2023, 25 (03) : 176 - 183
  • [14] Human Motor Neurons With SOD1-G93A Mutation Generated From CRISPR/Cas9 Gene-Edited iPSCs Develop Pathological Features of Amyotrophic Lateral Sclerosis
    Kim, Byung Woo
    Ryu, Jiwon
    Jeong, Ye Eun
    Kim, Juhyun
    Martin, Lee J.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2020, 14
  • [15] Correcting the PRKAG2 mutation in WPW patient's induced pluripotent stem cells using CRISPR/Cas9 eliminates arrhythmic firing patterns in the derived cardiomyocytes
    Ben Jehuda, R.
    Eisen, B.
    Shemer, Y.
    Mekies, L. N.
    Sperling, S. R.
    Gherghiceanu, M.
    Arad, M.
    Binah, O.
    EUROPEAN HEART JOURNAL, 2017, 38 : 817 - 817
  • [16] Generation of a heterozygous COL2A1 (p.G1113C) hypochondrogenesis mutation iPSC line, MCRIi019-A-7, using CRISPR/Cas9 gene editing
    Lilianty, Jinia
    Bateman, John F.
    Lamande, Shireen R.
    STEM CELL RESEARCH, 2021, 56
  • [17] Developing a C. elegans model to study SF3B1-driven Myelodysplastic Syndromes using CRISPR/Cas9 to introduce a point mutation and RNAi-mediated knockdown of sftb1.
    Tirado-Class, N.
    Rolle, C. E.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [18] Generation of R272Q, S156A and K572R RHOT1/Miro1 point mutations in iPSCs from a healthy individual using FACS-assisted CRISPR/Cas9 genome editing
    Schwarz, Lisa
    Casadei, Nicolas
    Fitzgerald, Julia C.
    STEM CELL RESEARCH, 2021, 55
  • [19] Towards highly specific genetic manipulation of the mouse cannabinoid CB1 receptor using CRISPR/Cas9: cell-type selective and region-specific CB1 knockout in the adult brain and generation of a CB1 point-mutation mouse line
    Remmers, F.
    Eshkind, L.
    Lange, M. D.
    Pape, H. -C.
    Lutz, B.
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (11) : 1557 - 1557